page-site
5 November 2019
Kit de communication (EN)
Content
Read also
Press release
3 August 2020
Iron-mediated cancer cell activity: a new regulation mechanism
Press release
19 October 2020
Intestinal Health : Macrophages lead the conversation between the microbiota and the colon
Press release
22 December 2020
Institut Curie and Google initiate a research collaboration using artificial intelligence (AI) for the analysis...
Press release
22 December 2020
COVID-19: early results of a large-scale study on the immune response against SARS-CoV-2 conducted with...
Press release
5 January 2021
Covid-19: biological bait in the form of vesicles to stop infection by the SARS-CoV-2 virus
Press release
21 January 2021
Autoimmune and inflammatory diseases associated with primary immune deficiencies
Press release
4 February 2021
Onxeo Enters Clinical Research Agreement with Institut Curie to Conduct a phase 1b/2 Clinical Trial...
Press release
16 April 2021
OncoDNA and Institut Curie test the clinical utility of personalized liquid biopsy in head and...
Press release
4 May 2021
“Flash » radiotherapy: another step towards clinical applications for Institut Curie and SIT
Press release
16 June 2021
Institut Curie applauds the €75 million fundraising achieved by its spin-off Mnemo Therapeutics
Press release
6 July 2021
Nanomedicine and new targeted therapies: the advances of Institut Curie at the ASCO 2021 Meeting
Press release
30 August 2021
Accelerating the pace of pediatric oncology research and innovating at Institut Curie, to better care...
Press release
6 September 2021
Research / From yellow to white and black again: the secret o the spider crab’s...
Press release
23 September 2021
Research / Breast cancers: ruptures in cell nuclei promotes tumor invasion
Press release
27 September 2021
New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted...
Press release
5 October 2021
PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010...
Press release
22 October 2021
Egle Therapeutics raises 40 million € Series Ato develop First-In-Class T-regulatory cells therapies based on...
Press release
28 October 2021
Institut Curie celebrates the centenary of Marie Curie’s trip to the United States
Press release
16 November 2021
Retinoblastoma: an ambitious project to preserve children’s sight
Press release
23 November 2021
Institut Curie equips its surgeons and radiologists with AVATAR MEDICAL’s virtual reality medical image solution
Perspectives
4 February 2022
Le Figaro / 4 février 2022 Cancer au féminin : halte au cumul des peines
Perspectives
27 February 2022
Le Figaro / 27 février 2022 « Politique de santé: quatre priorités pour aborder enfin les...
Press release
2 June 2022
ASCO 2022: Highly promising clinical innovations and breakthroughs at Institut Curie
Press release
4 June 2022
Hematology: new combination of treatments effective in patients with mantle cell lymphoma
Press release
5 June 2022
Pancreatic cancer: an original study on the benefits of adapted physical activity for patients
Perspectives
30 June 2022
Le Figaro / 30 juin 2022 En cancérologie, un été de tous les dangers
Perspectives
4 July 2022
Le Figaro / 4 juillet 2022 Mettre fin au grand désordre de la cancérologie mondiale_12940
Press release
8 August 2022
Manipulating chromosomes in living cells reveals that they are fluid
Press release
1 September 2022
Prof. Steven Le Gouill, new director of the hospital group at Institut Curie
Press release
7 September 2022
Fibroblasts and cancer: new targets for improving the effectiveness of immunotherapies in treating lung cancer
Perspectives
14 October 2022
Le Figaro / 14 octobre 2022 Cancer du col de l’utérus: finissons-en avec les inégalités...
Perspectives
6 November 2022
Le Figaro / 6 novembre 2022 «Pour un nouvel institut dédié aux cancers des femmes»_12967
Perspectives
24 November 2022
Santé : « L’augmentation du coût de l’énergie s’annonce stratosphérique dans le budget des établissements...
Press release
29 November 2022
Localising BRCA gene mutations to better treat ovarian cancer
Perspectives
6 December 2022
Débat sur la Convention sur la fin de vie avec Jonathan Denis et Alexis Burnod_12880
Perspectives
8 December 2022
Entretien « Anne-Vincent Salomon : je veux être optimiste pour tous les cancers du sein...
Press release
21 December 2022
Institut Curie study published in a Nature journal reporting excellent outcomes of Ibex AI solution...
Perspectives
23 December 2022
La lutte contre les cancers, un combat sur de multiples fronts_12868
Press release
2 January 2023
Radiotherapy at Institut Curie: a boost for state-of-the-art innovation
album
24 January 2023
Radiotherapy at the Institut Curie: boost for cutting-edge innovation
Press release
9 February 2023
Immunotherapy: a new two-in-one weapon against resistant tumors
album
13 February 2023
Protontherapy: unrivalled, ultra-precise « Curie » expertise to treat children
Press release
10 March 2023
Bilateral breast cancer: the first full study reveals that the tumors are independent of one...
Press release
29 March 2023
France’s very first therapy dog joins Institut Curie’s treatment team as a full-time member
Press release
11 May 2023
Identifying the role of copper paves the way for new therapeutic applications
Press release
15 June 2023
Major breakthroughs in the actions of the OECI and renewal of the “Comprehensive Cancer Center”...
Press release
26 June 2023
Institut Curie in Tanzania: Look Back at a Vast 4-year Project to Improve Cancer Care
Press release
29 August 2023
CATCHFIRE: An innovative tool to control the private lives of cells and view them via...
Scientific
29 August 2023
CATCHFIRE: An innovative tool to control the private lives of cells and view them via...
Press release
6 September 2023
Discovery of an original DNA repair system, bringing new hope for the treatment of breast...
Medical
18 September 2023
Pink October 2023 / Breast Cancer : understand the disease for better care
Press release
22 September 2023
Countering the effects of aging and the occurrence of cancers: new and promising results
Press release
11 October 2023
Pediatric cancers: Institut Curie’s expertise at the forefront of the international scene
Press release
20 October 2023
Bispecific antibodies, nanoparticles, epidrugs…: institut Curie’s latest progress at the ESMO Annual Meeting 2023
Press release
23 October 2023
ESMO 2023 / A new effective, innovative and personalized treatment for patients with a rare...
Press release
27 October 2023
The key role of “junk” DNA in the exhaustion of T cells in cancer
Scientific
27 October 2023
The key role of “junk” DNA in the exhaustion of T cells in cancer
Press release
30 October 2023
How do two cellular structures combine to give the green light to tumor dissemination?
Scientific
30 October 2023
How do two cellular structures combine to give the green light to tumor dissemination?
Press release
8 November 2023
Inauguration of Institut Curie’s new hospital in Saint-Cloud and launch of the cellular therapy platform
Resources
8 November 2023
Extention building of Institut Curie’s new hospital in Saint-Cloud
Press release
9 November 2023
The Institut Curie honors Michael Douglas, iconic actor and cancer prevention advocate, with the inaugural...
Press release
28 November 2023
New Integrated Research Center of Excellence in Pediatric Oncology to fight against cancers in children...
Press release
12 December 2023
Professor Alain Puisieux appointed by Institut Curie Supervisory Board as Chairman of the Executive Board
Press release
19 December 2023
Immunotherapy: long-term benefits on survival and relapse in a rare lymphoma
Press release
24 January 2024
Rare cancers: Institut Curie expertise leads to major breakthroughs in research and care
Press release
31 January 2024
Science and the transmission of knowledge: Institut Curie preserves the Pavillon des Sources while giving...
Press release
12 February 2024
Pediatric brain tumors: the innovations of Institut Curie towards new therapies and fewer after-effects
Press release
14 February 2024
The centromere: a crucial point of vulnerability during cell division
Press release
15 February 2024
New therapeutic avenues to improve the treatment of ovarian cancer
Press release
29 February 2024
World Triple Negative Breast Cancer Day: innovation to cure more women
Press release
10 April 2024
Pediatric oncology, cancer vaccine: promising results from Institut Curie presented at the AACR congress
Press release
30 April 2024
CellAction kicks off at Institut Curie: a unique platform in France to accelerate innovation and...
Press release
27 June 2024
Spotlight Medical Emerges from Stealth to Tackle the Critical Issue of Inadequate Cancer Treatments
Press release
4 July 2024
Dr. Claire Rougeulle, new Director of the Research Center of Institut Curie
Press release
4 July 2024
Pediatric cancer: the origin of the medulloblastoma detected, renewed hope
Press release
14 September 2024
Lung cancer: a novel combination of immunotherapies multiplies and prolongs the anti-tumor effect
Press release
12 November 2024
Radiotherapy: Institut Curie and Varian, a Siemens Healthineers company, sign a strategic framework agreement to...
Press release
15 November 2024
Institut Curie to Honor Jane Fonda with the Marie Curie Legacy Medal for her fight...
News
26 December 2024
Triple-negative breast cancer: new data in the regulation of the mTOR pathway
Press release
7 February 2025
Allo-CAR-T cells: one step closer to standardized and accessible cell therapies
Press release
12 February 2025
